Can you stop taking serputinib/serpatinib once you take it?

Selpercatinib (Selpercatinib) is a targeted therapy drug targeting specific gene mutations. It is mainly used to treat RET gene fusion-positive non-small cell lung cancer and thyroid cancer. Since its mechanism of action is to continuously inhibit abnormal signaling in tumor cells, thereby controlling the growth and spread of tumors, the continued use of the drug during treatment is crucial to maintaining the efficacy.

Typically, doctors will advise patients to continue taking seputinib as long as they do not experience serious side effects or disease progression. This is because once the drug is stopped, tumor cells may resume activity, causing the disease to rebound or worsen. Continuous medication can delay disease progression to the greatest extent and maintain the patient's quality of life and survival time.

Of course, clinically, the medication regimen will also be adjusted according to the patient's specific conditions. If the patient develops intolerable side effects or other health problems, the doctor may temporarily stop the medication or adjust the dose to ensure the patient's safety. During this period, patients need to communicate closely with their doctors to formulate a reasonable treatment plan to ensure that the medication is both effective and safe.

In general, although seputinib is not a drug that must be taken permanently, its continuous use is very important for disease control. Patients should follow the doctor's instructions and avoid stopping the medication on their own, so as not to affect the treatment effect and disease control. At the same time, timely feedback to the doctor on any discomfort during medication can be used to promptly adjust the treatment plan and achieve the best therapeutic effect.

Reference materials:https://en.wikipedia.org/wiki/Selpercatinib